-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Pyridoxal-[d5] 5'-phosphate
Category | Reverse Transcriptases (RTs) |
CAS | 1246818-16-5 |
Description | An isotope labelled Pyridoxal phosphate. Pyridoxal phosphate is the active form of vitamin B6. It is a coenzyme in a variety of enzymatic reactions. |
Product Information
Synonyms | 3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinecarboxaldehyde-d5; Pyridoxal-d5 Phosphate; Pyridoxal-d5 5-(Dihydrogen Phosphate); 2-Methyl-3-hydroxy-4-formyl-5-pyridyl-methylphosphoric Acid-d5; 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde-d5 5-Phosphate; Apolon B6-d5; Biosechs-d5; Codecarboxylase-d5; Coenzyme B6-d5; Hairoxal-d5; Hexermin P-d5; Hi-Pyridoxin-d5; Hiadelon-d5; NSC 82388-d5; PLP-d5; Phosphopyridoxal-d5; Piodel-d5; Pydoxal-d5; Pyridoxal-d5 Monophosphate; Vitazechs-d5 |
Molecular Weight | 252.17 |
Molecular Formula | C8H5D5NO6P |
Canonical SMILES | CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O |
Melting Point | >127°C (dec.) |
Purity | >95% |
Solubility | Soluble in DMSO (Slightly, Heated, Sonicated), Water (Slightly) |
Appearance | Light Yellow Solid |
Storage | Store at -20°C |
Complexity | 292 |
Exact Mass | 252.05595777 |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
Target | Reverse Transcriptase; Endogenous Metabolite |
XLogP3-AA | -1.1 |